The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Live Attenuated Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland.
The contract period is one year (influenza season 2023-2024). The procurement contains three options to extend the contract for the periods concerning influenza seasons 2024-2025, 2025-2026 and 2026-2027.
Estimated quantity for the contract period including options is 464.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the Call for tender refer to local time in Finland.
Call for Tenders Annexes:
Annex 1 Contract Live Attenuated influenza Vaccine (LAIV)
Annex 2 JYSE 2014 Supplies (updated version of April 2022)
Annex 3 Handi Service
Määräaika
Tarjousten vastaanottamisen määräaika oli 2022-12-01.
Hankinta julkaistiin 2022-10-26.
Toimittajat
Seuraavat toimittajat mainitaan hankintapäätöksissä tai muissa hankinta-asiakirjoissa:
Kohde Hankinnan laajuus
Otsikko:
“Live attenuated influenza vaccine (LAIV) 2023-2024 and options (2024-2025, 2025-2026, 2026-2027)
VN/5821/2022”
Tuotteet/palvelut: Rokotteet📦
Lyhyt kuvaus:
“The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your...”
Lyhyt kuvaus
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Live Attenuated Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland.
The contract period is one year (influenza season 2023-2024). The procurement contains three options to extend the contract for the periods concerning influenza seasons 2024-2025, 2025-2026 and 2026-2027.
Estimated quantity for the contract period including options is 464.000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Please note that all times given in the Call for tender refer to local time in Finland.
Call for Tenders Annexes:
Annex 1 Contract Live Attenuated influenza Vaccine (LAIV)
Annex 2 JYSE 2014 Supplies (updated version of April 2022)
Annex 3 Handi Service
1️⃣
Suorituspaikka: Suomi/Finland🏙️
Hankinnan kuvaus:
“The purpose of STM and the Customer is to procure Live Attenuated Quadrivalent Seasonal Influenza Vaccine (LAIV) belonging to the National Vaccination...”
Hankinnan kuvaus
The purpose of STM and the Customer is to procure Live Attenuated Quadrivalent Seasonal Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland. The tendered vaccine must be suitable for children aged between two and six years old.
More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare:
https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/influenza-vaccine/nasal-spray-influenza-vaccine-for-children
The Customer will implement the procurement on behalf of STM. The roles of STM and Customer are described in more detail in section "Presentation of the contracting authority".
The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders.
CONTRACT PERIOD
The contract´s duration is one year (influenza season 2023-2024). Estimated quantity for the contract period is 116.000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%.
The Contract period shall enter into force once the contract has been signed, and expire when all contractual duties have been performed. After the contract period, the Customer reserves the right for the option described in section "Description of renewals".
Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tender.
Näytä lisää Myöntämisperusteet
Hinta
Sopimuksen, puitesopimuksen tai dynaamisen hankintajärjestelmän kesto
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Kuvaus
Kesto: 12
Sopimuksen, puitesopimuksen tai dynaamisen hankintajärjestelmän kesto
Tämä sopimus voidaan uusia ✅ Kuvaus
Uudistusten kuvaus:
“The procurement contains three (3) option years (1+1+1) to extend the contract for the influenza seasons 2024-2025, 2025-2026 and 2026-2027. Estimated...”
Uudistusten kuvaus
The procurement contains three (3) option years (1+1+1) to extend the contract for the influenza seasons 2024-2025, 2025-2026 and 2026-2027. Estimated quantity for each option period is 116 000 doses (+/- 20%). More information in Annex 1 Contract Live Attenuated Influenza Vaccine (LAIV)
Näytä lisää
Lisätietoja:
“This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement...”
Lisätietoja
This procurement is detailed in the contract notice published on TED (Tenders Electronic Daily) online version and on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as in this Call for Tenders and its Annexes.
Oikeudelliset, taloudelliset, rahoitukselliset ja tekniset tiedot Osallistumisehdot
Luettelo ja lyhyt kuvaus olosuhteista:
“Please see sections Other information of the Call for Tenders and the European Single Procurement Document (ESPD).” Taloudellinen ja rahoituksellinen asema
Hankinta-asiakirjoissa mainitut valintaperusteet
Tekninen ja ammatillinen pätevyys
Hankinta-asiakirjoissa mainitut valintaperusteet
Sopimukseen liittyvät ehdot
Sopimuksen täytäntöönpanoehdot:
“Please see sections Other information of the Call for Tenders and the European Single Procurement Document (ESPD).”
Menettely Toimenpiteen tyyppi
Avoin menettely
Hallinnolliset tiedot
Tarjousten tai osallistumishakemusten vastaanottamisen määräaika: 2022-12-01
12:00 📅
Kielet, joilla tarjoukset tai osallistumishakemukset voidaan jättää: englanti 🗣️
Jäljempänä oleva aikataulu on ilmaistu kuukausina.
Vähimmäisaika, jonka kuluessa tarjoajan on pidettävä tarjous voimassa: 6
Tarjousten avaamista koskevat ehdot: 2022-12-01
13:00 📅
Tarjousten avaamista koskevat ehdot (paikka):
“Please note that the opening of tenders is an early estimate date. In addition the opening of the tenders is not a public event.
Please note that the online...”
Tarjousten avaamista koskevat ehdot (paikka)
Please note that the opening of tenders is an early estimate date. In addition the opening of the tenders is not a public event.
Please note that the online connection to the Supplier Portal can be periodically slow and the download time will take time. Please fill out the tenders information in good time before the deadline expires.
Täydentävät tiedot Tietoa toistumisesta
Tämä on toistuva hankinta ✅
Arvioitu aikataulu uusien ilmoitusten julkaisemiselle:
“The following procurement concerning Live Attenuated Influenza Vaccine will take a place in 2026. Please note this is only an estimation and the situation...”
Arvioitu aikataulu uusien ilmoitusten julkaisemiselle
Näytä lisää Tietoa sähköisistä työnkuluista
Sähköistä tilaamista käytetään
Sähköinen laskutus hyväksytään
Sähköistä maksua käytetään
Lisätietoja
“Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the...”
Tenderers may ask clarification questions using the Supplier Portal. The questions must be in English and will be answered in English. To guarantee the equal treatment of tenderers, questions posed in any other way cannot be answered.
All times given in the Call for tender refer to local time in Finland.
Ilmoitus tehdystä sopimuksesta (2023-02-17) Kohde Hankinnan laajuus
Lyhyt kuvaus:
“The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) requested...”
Lyhyt kuvaus
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) requested tenders for Live Attenuated Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland.
The contract period is one year (influenza season 2023-2024). The procurement contains three options to extend the contract for the periods concerning influenza seasons 2024-2025, 2025-2026 and 2026-2027.
Näytä lisää
Hankinnan kokonaisarvo (ilman arvonlisäveroa): EUR 7 656 000 💰
Kuvaus
Hankinnan kuvaus:
“The purpose of STM and the Customer was to procure Live Attenuated Quadrivalent Seasonal Influenza Vaccine (LAIV) belonging to the National Vaccination...”
Hankinnan kuvaus
The purpose of STM and the Customer was to procure Live Attenuated Quadrivalent Seasonal Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland. The tendered vaccine must be suitable for children aged between two and six years old.
More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare:
https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/influenza-vaccine/nasal-spray-influenza-vaccine-for-children
Näytä lisää Tietoa vaihtoehdoista
Vaihtoehdot ✅
Vaihtoehtojen kuvaus:
“The procurement contains three (3) option years (1+1+1) to extend the contract for the influenza seasons 2024-2025, 2025-2026 and 2026-2027”
Menettely Hallinnolliset tiedot
Tätä menettelyä koskeva aiempi julkaisu: 2022/S 210-600779
Sopimuksen tekeminen
1️⃣
Sopimuksen numero: 1
Otsikko:
“Live attenuated influenza vaccine (LAIV) 2023-2024 and options (2024-2025, 2025-2026, 2026-2027)”
Sopimuksen tekopäivä: 2023-02-16 📅
Tietoa tarjouskilpailuista
Saatujen tarjousten määrä: 1
Pk-yrityksiltä saatujen tarjousten määrä: 0
Sähköisesti vastaanotettujen tarjousten määrä: 1
Toimeksisaajan nimi ja osoite
Nimi: AstraZeneca
Kansallinen rekisterinumero: FI01969411
Postiosoite: Itsehallintokuja 6
Postitoimipaikka: Espoo
Postinumero: 02600
Maa: Suomi 🇫🇮
Alue: Suomi/Finland🏙️
Toimeksisaaja on pk-yritys
Tiedot sopimuksen/erän arvosta (ilman alv:tä)
Sopimuksen/osuuden kokonaisarvo: EUR 7 656 000 💰